Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: Results from a multicenter atrial fibrillation registry study

Journal of the American Medical Directors Association

Volumn 15, Issue 8, 2014, Pages 576-581

  Huang, Bi ^a   Yang, Yanmin ^a   Zhu, Jun ^a   Liang, Yan ^a   Zhang, Han ^a   Tian, Li ^a   Shao, Xinghui ^a   Wang, Juan ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Anticoagulation; Atrial fibrillation; Chronic obstructive pulmonary disease (COPD); Outcomes

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PROPAFENONE; SOTALOL; WARFARIN; ANTICOAGULANT AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVERSION; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; ANTICOAGULATION; ATRIAL FIBRILLATION; CLINICAL FEATURE; COMORBIDITY; INCIDENCE; MORBIDITY; SMOKING; ADULT; CAUSE OF DEATH; CHINA; CLINICAL TRIAL; COMPLICATION; MIDDLE AGED; MULTICENTER STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTER; RISK FACTOR; STROKE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CAUSE OF DEATH; CHINA; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; RISK FACTORS; STROKE;

EID: 84905060597     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2014.04.009     Document Type: Article

References (35)

1. Chinitz J.S., Castellano J.M., Kovacic J.C., et al. Atrial fibrillation, stroke, and quality of life. Ann N Y Acad Sci 2012, 1254:140-150.
2. Hu D., Sun Y. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. JAm Coll Cardiol 2008, 52:865-868.
3. Stewart S., Hart C.L., Hole D.J., et al. Apopulation-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002, 113:359-364.
4. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 2006, 27:1979-2030.
5. Sidney S., Sorel M., Quesenberry C.J., et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005, 128:2068-2075.
6. Lopez C.M., House-Fancher M.A. Management of atrial fibrillation in patients with chronic obstructive pulmonary disease. JCardiovasc Nurs 2005, 20:133-140.
7. Dankner R., Goldbourt U., Boyko V., et al. Predictors of cardiac and noncardiac mortality among 14,697 patients with coronary heart disease. Am J Cardiol 2003, 91:121-127.
8. Hawkins N.M., Petrie M.C., Jhund P.S., et al. Heart failure and chronic obstructive pulmonary disease: Diagnostic pitfalls and epidemiology. Eur J Heart Fail 2009, 11:130-139.
9. Lainscak M., Hodoscek L.M., Dungen H.D., et al. The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure. Wien Klin Wochenschr 2009, 121:309-313.
10. Hozawa A., Billings J.L., Shahar E., et al. Lung function and ischemic stroke incidence: The Atherosclerosis Risk in Communities study. Chest 2006, 130:1642-1649.
11. Truelsen T., Prescott E., Lange P., et al. Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. Int J Epidemiol 2001, 30:145-151.
12. Leavitt B.J., Ross C.S., Spence B., et al. Long-term survival of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass surgery. Circulation 2006, 114:I430-I434.
13. Wu C., Camacho F.T., Wechsler A.S., et al. Risk score for predicting long-term mortality after coronary artery bypass graft surgery. Circulation 2012, 125:2423-2430.
14. Fang X., Wang X., Bai C. COPD in China: The burden and importance of proper management. Chest 2011, 139:920-929.
15. Sin D.D., Man S.F. Chronic obstructive pulmonary disease: A novel risk factor for cardiovascular disease. Can J Physiol Pharmacol 2005, 83:8-13.
16. Finkelstein J., Cha E., Scharf S.M. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis 2009, 4:337-349.
17. Feary J.R., Rodrigues L.C., Smith C.J., et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: A comprehensive analysis using data from primary care. Thorax 2010, 65:956-962.
18. Barnes P.J., Celli B.R. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009, 33:1165-1185.
19. Hole D.J., Watt G.C., Davey-Smith G., et al. Impaired lung function and mortality risk in men and women: Findings from the Renfrew and Paisley prospective population study. BMJ 1996, 313:711-715. 715-716.
20. Fuso L., Incalzi R.A., Pistelli R., et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995, 98:272-277.
21. Steer J., Gibson J., Bourke S.C. The DECAF Score: Predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax 2012, 67:970-976.
22. Ryynanen O.P., Soini E.J., Lindqvist A., et al. Bayesian predictors of very poor health related quality of life and mortality in patients with COPD. BMC Med Inform Decis Mak 2013, 13:34.
23. Waatevik M., Skorge T.D., Omenaas E., et al. Increased prevalence of chronic obstructive pulmonary disease in a general population. Respir Med 2013.
24. Andreas S., Anker S.D., Scanlon P.D., et al. Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest 2005, 128:3618-3624.
25. Rycroft C.E., Heyes A., Lanza L., et al. Epidemiology of chronic obstructive pulmonary disease: A literature review. Int J Chron Obstruct Pulmon Dis 2012, 7:457-494.
26. Chen J., Radford M.J., Wang Y., et al. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. JAm Coll Cardiol 2001, 37:1950-1956.
27. Short P.M., Lipworth S.I., Elder D.H., et al. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: A retrospective cohort study. BMJ 2011, 342:d2549.
28. Ni Y., Shi G., Wan H. Use of cardioselective beta-blockers in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, placebo-controlled, blinded trials. JInt Med Res 2012, 40:2051-2065.
29. Jones T.E., Ruffin R.E., Arstall M. Cardiologists are more willing to prescribe beta-blockers than respiratory physicians: An Australasian clinical scenario survey. Intern Med J 2013, 43:507-512.
30. Lip G.Y. The role of aspirin for stroke prevention in atrial fibrillation. Nat Rev Cardiol 2011, 8:602-606.
31. Clarkesmith D.E., Pattison H.M., Lip G.Y., et al. Educational intervention improves anticoagulation control in atrial fibrillation patients: The TREAT randomised trial. PLoS One 2013, 8:e74037.
32. Sethi S., Mahler D.A., Marcus P., et al. Inflammation in COPD: Implications for management. Am J Med 2012, 125:1162-1170.
33. Gage B.F., Waterman A.D., Shannon W., et al. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001, 285:2864-2870.
34. Camm A.J., Kirchhof P., Lip G.Y., et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010, 12:1360-1420.
35. Donaldson G.C., Hurst J.R., Smith C.J., et al. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest 2010, 137:1091-1097.